Applied Filters
SPC export waiver: a long road ahead
The European Commission’s proposed export waiver for supplementary protection certificates is likely to face opposition and may be delayed by EU parliamentary changes, says Trevor Cook of WilmerHale.
LSIPR 50 2018: Martyn Andrews
Martyn Andrews was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.
LSIPR 50 2018: Alisa Harbin
Alisa Harbin was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.
Combination SPCs: shaken and stirred
Following a CJEU decision in July, and with two more cases on the horizon, Joel Beevers and Michael Pears of Potter Clarkson report on whether an active ingredient (or combination of active ingredients) is ‘protected by a basic patent’, as required for a supplementary protection certificate.
LSIPR 50 2018: Emma Walmsley
Emma Walmsley was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Antoine Petit
Antoine Petit was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Kim Nasmyth
Kim Nasmyth was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Manuel Salmeron-Sanchez and Matthew Dalby
Manuel Salmeron-Sanchez and Matthew Dalby were selected in the LSIPR 50 2018 publication for their influence on the life sciences industry. They featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Michel Sidibé
Michel Sidibé was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
The future of precision medicine part 2: data is king
In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports.
